WAKAMOTO PHARMACEUTICAL CO.,LTD.
ワカモトセイヤクカブシキガイシャ

Industry

Major Drugs

Feature

Biotechnology & Drugs

Product / Service

・眼科手術補助剤・眼科用副腎皮質ホルモン剤「マキュエイド眼注用40mg」、抗炎症点眼剤「ジクロード点眼液」、アレルギー性結膜炎治療剤「ゼペリン点眼液」
・緑内障・高眼圧症治療剤「リズモンTG点眼液」、緑内障・高眼圧症治療点眼後発薬、乳酸菌製剤
・眼科手術補助剤、眼科用アデノウイルス抗原検出キット

Business content

Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and nonprescription drugs. Its operations are carried out through the following segments: Medicine, NonPrescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs. The NonPrescription Drugs segment offers overthecounter (OTC) drugs, quasi drugs and health food products. The Special Sales segment deals with the manufacture and sale of pharmaceutical raw materials, export products, intermediate products, and other products for pharmaceutical companies. The Others segment includes real estate leasing business. The company was founded in April 1929 and is headquartered in Tokyo, Japan.

Listed market

Tokyo Stock Exchange 1st Section

Listing date

1949/05/01

Stock code

4512

EDINET code

E00928

Corporate number

1010001035010

Date of Establishment

1933/01/15

History

WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japanbased pharmaceutical company. The Ethical Pharmaceutical segment is engaged in the manufacturing and sale of ophthalmic pharmaceuticals, including ophthalmic solutions, and ophthalmic generics used for the treatment of glaucoma and ocular hypertension, as well as auxiliaries for ophthalmic surgery, among others. The Cosmeceutical segment is engaged in the manufacturing and sale of cosmeceuticals, medicated toothpastes and other quasi drugs. The Special Sales segment provides lactobacillus products and ophthalmic solutions to overseas market, as well as active pharmaceutical ingredients (APIs) and other products to domestic market in Japan.

Phone number

03-3279-0371

Head office location

〒103-8330 2-2-2, Nihombashihon-cho

Representative

Nobuyuki Kamiya

Nearest station

三越前

Number of employees (non-consolidated)

337 employees

Average age

43.5 years

Average annual income

5.21M (JPY)

Average length of service

18.1 years

Capital

3395.0M (JPY)

Balance sheet

End of March

Performance

settlement term sales (million yen)
201703     10,830(3.2 %)
201803     10,900(0.6 %)
201903     10,739(1.5 %)
The contents written above is information collected on December 14th, 2019.
We make every effort to ensure the accuracy of this information, but the information might change.
Also, there is a possibility that this information may be incorrect due to artificial tampering by a third party or malfunction of the equipment.
This information is to provide information only and is not intended to sell or solicit financial products.
Next Beat Co., Ltd. is not responsible for any judgments made based on this information.